Tofflon Group

Expertise in Biopharmaceutical

*Unit:RMB

Till 2024-12-12

CGT Solution

CGT includes immune cell therapy, stem cell therapy, gene therapy, large and small nucleic acid therapy and oncolytic virus therapy, which gradually shows therapeutic potential in clinic. However, the production of related drugs has stricter regulatory requirements and complex technological processes, resulting in higher drug costs and higher patient treatment costs. Tofflon is a pharmaceutical equipment company that laid out related fields earlier in China. It has built two systems of space sealing solutions and product sealing solutions for cell therapy drugs, participated in the formulation of a number of industry standards, and has been verified by many well-known domestic enterprises, helping enterprises optimize production links, reduce production costs, and ultimately benefit doctors and patients.

Biopreparation Solution

Biological products are playing an increasingly prominent role in drug research and development. A new generation of biotechnology products, such as antibody drugs, new vaccines and ADC, have gradually matured and become the mainstream way of disease treatment and prevention. Tofflon can provide reliable bioreactors, separation and purification systems, liquid preparation systems, stock solution freezing storage systems, wastewater inactivation systems and supporting process consumables. It has two sets of disposable and stainless steel solutions, providing customers with technical support and process support in all fields of equipment, process and engineering, and helping enterprises to put drugs into production and market quickly.

Chemical Preparation Solution

Tofflon is an early equipment supplier in the field of research and development of preparations in China, especially in the field of freeze-drying machine and technology for more than 30 years. We have professional process development platforms such as injection laboratory, complex preparation preparation laboratory and solid preparation pilot laboratory. Tofflon participated in the writing and revision of many regulations and industry standards, maintained high-frequency and close exchanges and discussions with industry experts, continuously explored the science of drug manufacturing and the scientific manufacturing of drug machines, and strived to build a new generation of drug manufacturing platform.

CGT Solution

Tofflon Product Centers

1993-2003 Tofflon focus on the R&D of lyophilization and application in pharmaceutical production and become the mainstream brand of freeze dryers in China. 2003-2013 Layout of liquid preparation system, filling system, feeding and discharging system, specific pathogen-free, inspection, and packaging system. Become a well-known domestic preparation systematic solution supplier. 2013-Present Established pharmaceutical engineering and biotechnology team, committed to becoming "Smart Pharma Factory Provider". Created a new generation of pharmaceutical manufacturing platform, and supply technical support and process guarantee in all fields of equipment, process and engineering.

Frontier Cases

With the vigorous development of biomedical industry, pharmaceutical equipment faces more challenges in compliance, stability and efficiency, and reliable equipment greatly improves the production process of drugs. We have always insisted on exploring the science of pharmaceutical manufacturing and the scientific manufacturing of pharmaceutical machines, devoted ourselves to developing more advanced pharmaceutical manufacturing platforms, and successfully developed a number of domestic leading pharmaceutical equipment and systems to grow together with the pharmaceutical industry.

Investor Relations

28.38

+0.91[ 3.22% ]

As of Beijing Time AM 01:49 2024-12-12

The provided stock information is for reference only and is not intended for trading purposes

The stock price information is provided by a third-party Shanghai Stock Exchange

  • 28.66 Highest (Yuan)
  • 26.97 Lowest(Yuan)
  • 7214 Number of Traded Stocks (lots)
  • 1096 Transaction Amount (Thousands Of Yuan)

Newsroom

Grow With Us

Systematization Internationalization Digitalization & Intelligentization
Copyright © 2020-2021 Tofflon Science and Technology Group Co., Ltd. All Rights Reserved. Shanghai ICP No.13216461 -1